Where Quality doesn’t begin and end with audit

Providing you with bespoke worldwide quality consultancy, training and auditing services

Webinar – Tuesday 18th May – 16:00 BST

Benefits of having a QMS and why do I need one?

People and time are precious, and that’s why Quality Management Systems are critical in any business.

In this webinar we’ll be breaking it down into 2 sections

1 – What is a QMS? (The Concept)

2 – Why have a QMS? (The benefits)

At the end of the webinar, we’ll be conducting a Q&A section to help you with your execution strategy.

Register Your Place

Delivering Expertise in Research Quality

Located in Edinburgh, Scotland, with Associates in six countries, we provide international audit, consultancy, and training services to the clinical, health services, life sciences, biotechnology, scientific industries, and academia.

Our diverse team brings over 200 years of global regulatory experience from NHS, academia, start-up biotechs to worldwide pharma and medical devices.

We are renowned for providing a tailored service designed to meet your requirements.


Agile, simple, accurate and pragmatic solutions and support


Discover our range of remote/face to face, public and internal training courses

Quality Assurance

Discover our breadth of cost-effective and credible QA services

About Us

What makes us different and meet the experienced team


Industry news, white papers, case studies, what we are up to, and more

Contact Us

We would love to hear from you to discuss your requirements

Our Experience

Training & Consulting Projects
Number of Clients
Number of Countries

Our News and Articles

  • Senior Opportunities in Quality

Senior Opportunities in Quality Assurance

Demand for our laboratory Quality Assurance services continues to grow, resulting in vacancies for Senior or Principal Associate positions. These positions offer exciting opportunities for [...]

Tower Mains Weekly Newsletter 29th April 2021

Tower Mains Weekly Newsletter Industry Updates EC approves GSK’s JEMPERLI (dostarlimab), the first anti-PD-1 therapy approved for endometrial cancer The European Commission (EC) has granted [...]